Screener
Prime Medicine PRME Accretion (Amortization) of Discounts and Premiums, Short-Term Investments
Accretion (Amortization) of Discounts and Premiums, Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept prme:AccretionAmortizationOfDiscountsAndPremiumsShortTermInvestments.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's accretion (amortization) of discounts and premiums, short-term investments?
- Prime Medicine (PRME) reported accretion (amortization) of discounts and premiums, short-term investments of $312K in Q2 2026.
- How has Prime Medicine's accretion (amortization) of discounts and premiums, short-term investments changed year-over-year?
- Prime Medicine's accretion (amortization) of discounts and premiums, short-term investments decreased by 24.1% year-over-year, from $411K to $312K.
- What does accretion (amortization) of discounts and premiums, short-term investments mean?
- Accretion (Amortization) of Discounts and Premiums, Short-Term Investments as reported by Prime Medicine, Inc. Common Stock.
Ask your AI about Prime Medicine's accretion (amortization) of discounts and premiums, short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude